Explore the vast range of titles available.

Animal-related injuries remain a neglected public health issue in rural Tanzania, exacerbated by limited access to care and varied occupational exposures. While some studies have examined bite management in tertiary hospitals, little is known about the situation at the primary healthcare (PHC) level. This study explored clinical presentations, management and outcomes of animal-related injuries in a rural Tanzanian setting, using Mkinga District as a case study. A mixed-methods study was conducted in February 2024 across 29 PHC facilities in Mkinga, Tanzania. The quantitative component involved a retrospective audit of animal-related injury records from 2019 to 2023. The qualitative component comprised 10 interviews with facility in-charges to explore clinical decision-making, treatment approaches, and outcomes. Quantitative data were analyzed using SPSS; thematic analysis was applied to the qualitative transcript. A total of 351 cases were documented. Symptom data were missing in over 70% of records, limiting clinical profiling. Among recorded cases, corticosteroids (55%) and antihistamines (53%) were commonly used, especially for insect and dog bites. Antibiotics were administered in insect stings (26%) and dog bites (23%), and analgesics were frequently used for insect bites. Antidotes were most common in dog (58%) and snake bites (26%). Of two cat bite cases, only one received antibiotics; neither received tetanus toxoid, despite the known infection risk. Qualitative findings highlighted three themes: clinical presentations, treatment modalities, and outcomes. Respondents described primary (e.g., bleeding, pain) and systemic (e.g., respiratory distress, neurological signs) symptoms. Treatment involved a mix of pharmacological, non-pharmacological, and traditional methods. While most patients recovered, some experienced complications or death. PHC facilities manage most animal-related injuries effectively, but gaps in documentation, guideline adherence, and referral systems remain. Strengthening provider training, improving resources, and engaging traditional healers may enhance timely care. Broader surveillance and community education are critical to reducing preventable harm.

ABSTRACT Background In 2018, the World Health Organization (WHO) called on member states to assess the burden of animal-related injuries. Tanzania is among the countries with no adequate data. This study sought to assess the burden of venomous bites and stings in a rural setting in Tanzania. Methods A retrospective study was conducted in February, 2024 to gather information from 29 selected primary healthcare (PHC) facilities in one rural setting. We used a checklist to retrieve data on venomous bites and stings from 2019 through 2023 from the patient records. Results Of the 476,928 patient records screened, 212 (0.04%) were identified as cases of venomous bites and stings. The majority of cases (n = 72, 34%) occurred among individuals aged 25–44 years, and 111 (52%) were male. Snakebites accounted for the largest proportion of cases (n = 63, 30%), followed by bee stings (n = 27, 13%), wasp stings (n = 15, 7%), and scorpion stings (n = 14, 7%). Number of recorded venomous bites and stings ranged from 30 in 2019 to 61 in 2023. Conclusion Despite their low overall incidence, the rising trend of venomous bites and stings highlights the need for strengthened surveillance and targeted prevention efforts.

To curb HIV infection rate in Tanzania, antiretroviral therapy (ART) has been scaled up since 2006, and in 2019, the country shifted to regimen including dolutegravir as a default first line. We assessed the success of ART and the contribution of HIV drug resistance (HIVDR) to unsuppressed viral loads. Between February and May 2023 a cross-sectional survey with random sampling was conducted in the six clinics in an urban cohort in Dar es Salaam. Patients with unsuppresed viral loads (local criteria viral load (VL) ≥ 1000 copies/mL) were tested for HIVDR mutations using the WHO adapted protocol for plasma samples. Mutations were interpreted using the Stanford HIVDR database. In total 600 individuals participated in this survey, the majority were female (76.83%), mean age ( ± standard deviation) was 44.0 ( ± 11.6) years. The median duration on ART (interquartile range) was 6.5 (3.9–10.2) years. Approximately 99% were receiving tenofovir + lamivudine + dolutegravir as a fixed dose combination. VL testing was successful in 99.67% (598/600) of survey patients and only 33 had VL ≥ 1000 copies/mL, resulting in a viral suppression level of 94.48% (565/598, 95% CI 92.34–96.17%). For 23 samples, protease and reverse transcriptase (RT) genotyping were successful, with 13 sequences containing RT inhibitor surveillance drug resistance mutations (SDRMs) (56.5%). No SDRM against protease inhibitors were detected. Thirty samples were successfully genotyped for integrase with 3 sequences (10.08%) containing integrase strand transfer inhibitor (INSTI) SDRMs. In samples successfully genotyped in the three genetic regions, 68.18% (16/22) had a genotypic susceptibility score (GSS) ≥ 2.5 for the concurrent regimen, implying factors beyond drug resistance caused the unsuppressed viral load. For five patients, GSS indicated that HIVDR may have caused the unsuppressed viral load. All three patients with INSTI resistance mutations were highly resistant to dolutegravir and accumulated nucleoside and non-nucleoside RT inhibitor HIVDR mutations. Although in this cohort the last 95 UNAIDS target was almost achieved, HIVDR mutations, including INSTIs resistance mutations were detected in HIV-positive individuals taking ART for at least one year. We recommend the design and implementation of high-impact interventions to prevent the increase of HIVDR, failure of dolutegravir and address the non-resistance factors in the study area.

Antimicrobial use (AMU) is one of the major drivers of emerging antimicrobial resistance (AMR). The surveillance of AMU, which is a pillar of AMR stewardship (AMS), helps devise strategies to mitigate AMR. This descriptive, longitudinal retrospective study quantified the trends in human antibiotics utilization between 2010 and 2016 using data on all antibiotics imported for systemic human use into Tanzania’s mainland. Regression and time series analyses were used to establish trends in antibiotics use. A total of 12,073 records for antibiotics were retrieved, totaling 154.51 Defined Daily Doses per 1000 inhabitants per day (DID), with a mean (±standard deviation) of 22.07 (±48.85) DID. The private sector contributed 93.76% of utilized antibiotics. The top-ranking antibiotics were amoxicillin, metronidazole, tetracycline, ciprofloxacin, and cefalexin. The DIDs and percentage contribution of these antibiotics were 53.78 (34.81%), 23.86 (15.44), 20.53 (13.29), 9.27 (6.0) and 6.94 (4.49), respectively. The time series model predicted a significant increase in utilization (p-value = 0.002). The model forecasted that by 2022, the total antibiotics consumed would be 89.6 DIDs, which is a 13-fold increase compared to 2010. Government intervention to curb inappropriate antibiotics utilization and mitigate the rising threat of antibiotic resistance should focus on implementing AMS programs in pharmacies and hospitals in Tanzania.

Background This study aimed to analyzed healthcare providers’ (HCPs) experiences in managing animal-related injuries, including bites and stings, focusing on challenges and opportunities in rural Tanzania. Methods In February 2024, an exploratory qualitative study was conducted at selected primary health care (PHC) facilities in Mkinga District, Tanga Region, as a proxy of a rural setting in Tanzania. Ten HCPs in the selected facilities were in-depth interviewed using an interview guide. All interviews were audio-recorded, transcribed, and analysed using a thematic approach. Results From the experiences of HCPs, the challenges identified include reliance on traditional treatments, low community awareness of available services, out-of-pocket payment, and the high cost of antivenoms. Additionally, system and infrastructure limitations, workforce shortages, and a shortage of critical medical resources were revealed. However, opportunities exist to improve victim management. These include HCPs’ readiness to treat victims, engagement of community health workers, resource availability, and supportive financial policies. Conclusion Access to healthcare for victims of animal-related injuries in rural settings is limited by socio-cultural practices, poverty, and poor infrastructure. However, leveraging existing opportunities, including the readiness of HCPs, health insurance schemes, and functional cold chain systems, along with improving community awareness and road networks, could significantly enhance timely access to care among victims.